Power Law company profile

Pear Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2013 Unicorn

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need

Valuation

$690K

Market cap · 2026

Revenue

$13M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

13 investors on Pear Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Novartis

JAZZ Venture Partners

Bridge Builders Collaborative

Arboretum Ventures

5AM Ventures

Series B+ 8 investors entered at this stage

SoftBank

Temasek

Trustbridge Partners

Pilot House Ventures

SoftBank Vision Fund

EDBI

Shanda Group

QUAD Investment Management

Global footprint

Where Pear Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

410 monthly visits
across markets

🇪🇬 Egypt97.6%

Top 1 markets shown

Patent intelligence

$9M patent portfolio · 8 active families

Estimated portfolio value

$9M

1348.7% of market cap · 761.4× smaller than top peer Janssen Vaccines ($7.1B)

8 active patent families

Where Pear Therapeutics innovates Data processingElectronic equipmentPharmacologyInternal medicineBehavioral therapy

Where Pear Therapeutics concentrates vs peers

Each axis is a top-10 topic across Pear Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Pear Therapeutics

An AI-synthesized read of the highest-engagement posts about Pear Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pear Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles